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We previously generated a monoclonal antibody (mAb), 
ROCA 1, which binds preferentially to rostral versus caudal 
sympathetic ganglia and intercostal nerves. Two other mAbs, 
ROCA2 and B2C11, bind to the same structures but not in 
rostrocaudal gradients. All three mAbs recognize a 26 kDa 
cell surface protein. Amino acid sequence data obtained 
from the affinity purified 26 kDa protein showed some ho-
mology with human CD9, a tetraspan protein implicated in 
intercellular signaling in hematopoietic cells. Using the PCR, 
we obtained cDNA clones representing the entire rat CD9 
coding sequence from sciatic nerve and sympathetic gan-
glia. ROCA 1, ROCA2, and B2C11 each immunoprecipitate a 
26 kDa protein from CHO cells stably transfected with one 
of the clones, demonstrating that the ROCA cell surface 
antigen is indeed rat CD9. We find that CD9 mRNA is widely 
expressed, with particularly high levels present in a number 
of neural tissues. In situ hybridization demonstrates that 
peripheral neurons and Schwann cells, as well as adrenal 
chromaffin cells express CD9 mRNA. Consistent with im-
munoblot analyses showing that, unlike the ROCA 1 epitope, 
the 26 kDa protein is not expressed in a rostrocaudal gra-
dient, we find similar levels of rat CD9 mRNA in rostral and 
caudal intercostal nerves. In developing postnatal rat sciatic 
nerve, CD9 mRNA levels are coordinately regulated with the 
expression of myelin genes. These results provide another 
example of a cell surface protein expressed by both he-
matopoietic and neural cells, and suggest a role for CD9 in 
intercellular signaling in the nervous system. 
[Key words: CD9, tetraspan family, ROCA antigen, neu-
rospecification, Schwann cell, platelets, adrenal chromaffin 
cells, myelin, cell surface] 
Cell surface proteins play fundamental roles in cell-cell inter-
actions in the nervous and hematopoietic systems. In the he-
matopoietic system, some of these roles include platelet acti-
vation and aggregation, lymphocyte trafficking, and tumor cell 
motility. In the nervous system, cell surface proteins play key 
roles in neuron-neuron and neuron-glia interactions, and direct 
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the migration of neurons and glia, as well as axon outgrowth, 
guidance, and fasciculation. Many of these proteins belong to 
four major cell adhesion receptor families: cadherins, lg super·· 
family, integrins, and selectins (Hynes and Lander, 1992). Mosr 
of these proteins possess single transmembrane domains or are 
linked to the membrane via a phosphoinositol anchor, and they 
contain one or more lg domains, an EGF or fibronectin repeat, 
and a cysteine-rich repeat or a kinase domain. Hematopoietic 
and neural cells express members of each family, with the ex-
ception of the selectins, which have thus far been identified only 
in hematopoietic cells. 
A new superfamily of cell surface proteins known as the te-
traspan (Gil et al., 1992) or transmembrane 4 superfamily 
(TM4SF; Wright et al., 1993) has recently been identified. Mem-
bers of this family include (1) the leucocyte proteins CD9 
(Boucheix et al., 1991; Lanza et al., 1991; Martin-Alonso et al., 
1992; Mitamuraet al., 1992; Rubinstein eta!., I 993a,b), MRP-1 
(identical to human CD9; Miyake et al., 1991), CD37 (Classon 
et al., 1989), CD53 (Amiot, 1990; Angelisova et al., 1990), OX-
44 antigen (rat homolog of human CD53; Bellacosa et al., 1991 ), 
CD63/ME 491 (Hotta et al., 1988; Metzelaar et al., 1991 ), ADI 
(rat homolog of human CD63/ME 491; Nishikata et al., 1992), 
R2/C33/IA4 (Gaugitsch et al., 1991; Imai et al., 1992; Gil et 
al., 1992, respectively), TAPA-1 (Oren et al., 1990; Andria et 
al., 1991 ), and A 15 (Emi et al., 1993); (2) the tumor-associated 
antigens C0-029 (Szala et al., 1990) and L6 (Marken et al., 
1992); (3) the lung epithelial protein TI-I (Kallin et al., 1991); 
and (4) the schistosome surface proteins Sm23 (Wright et al., 
1990) and Sj23 (Davern et al., 1991 ). The current model for the 
structure of superfamily members consists of four transmem-
brane domains divided by two extracellular loops, with cyto-
plasmic N- and C-termini (Horejsi and Vlcek, 1991; Levy et 
al., 1991; Reynolds et al., 1992; Tomlinson et al., 1993). While 
many of these proteins are known to be expressed in hemato-
poietic and a variety of other cells, little information is available 
on their distribution in the nervous system (Kemshead et al., 
1982; Komada et al., 1983; Ross et al., 1986; Von dem Borne 
et al., 1989; Oren et al., 1990). Although the in vivo function of 
these proteins has yet to be elucidated, antibody perturbation 
experiments implicate certain tetraspan family members in neu-
ral cell adhesion, motility, and growth regulation (Anton et al., 
1994; Hadjiargyrou and Patterson, 1994). 
We previously demonstrated that the ROCA! mAb recog-
nizes two distinct proteins (60 kDa and 26 kDa) in membrane/ 
cytoskeletal fractions of peripheral nerves and ganglia. The 60 
kDa protein is expressed at higher levels in rostral than in caudal 
intercostal nerves, and has been identified as peripherin (Ka-
prielian and Patterson, 1993). In contrast, it is the ROCA! 
epitope on the 26 kDa protein, and not the protein itself, that 
is preferentially visualized immunohistochemically in rostral 
nerves and ganglia (Suzue et al., 1990; Kaprielian and Patterson, 
1993). We now have three mAbs against the 26 kDa protein, 
ROCA!, ROCA2 (Kaprielian and Patterson, 1993; Tole and 
Patterson, 1993), and B2Cl I (Akeson and Warren, l 984f. Ami-
no acid sequence data obtained from the affinity purified 26 
kDa protein raised the possibility that it could be the rat ho-
molog of human CD9 (Kaprielian and Patterson, 1993). Here 
we describe the isolation of cDNA clones encoding rat CD9, 
confirm that it is the ROCA surface antigen, and define the 
regions of CD9 that contain the epitope for each mAb. In ad-
dition, we report the tissue, cell type, positional, and develop-
mental expression of rat CD9 mRNA. 
Materials and Methods 
Antibodies 
ROCA! and ROCA2 are both IgG2b mouse mAbs that have been 
previously characterized (Suzue et al., 1990; Kaprielian and Patterson, 
1993; Tole and Patterson, 1993). B2Cl I is an IgG2a mouse mAb that 
has also been previously characterized (Akeson and Warren, 1984). 
Protein preparations and immunoblotting 
NP40 extracts ofadult rat peripheral nerve membrane/cytoskeletal frac-
tions were prepared as previously described (Kaprielian and Patterson, 
1993). Platelet extracts were derived from membrane/cytoskeletal frac-
tions of platelet rich plasma, prepared according to Boucheix et al., 
1983. In brief, blood from freshly killed adult rats was first collected 
into 1/9 volume of0.13 M sodium citrate, and then centrifuged at 1000 
rpm ( 150 x g) for 10 min in a Sorvall SS 34 rotor. The resulting pellet 
was discarded, while the supernatant, which contains the platelet-rich 
plasma (PRP), was then centrifuged at 100,000 x gfor I hrin a Beckman 
70 Ti rotor. The pellets were resuspended in protease inhibitor-con-
taining low-salt homogenization buffer (Kaprielian and Patterson, 1993). 
This material, which will be referred to as the platelet membrane/cy-
toskeletal fraction, was either used immediately or frozen at -80°C until 
further use. Detergent extracts were obtained by solubilizing the mem-
brane/cytoskeletal fraction with 1% NP40 as previously described (Ka-
prielian and Patterson, 1993). Protein concentration was determined 
by the method of Lowry et al. ( 19 51 ), and immunoblots were performed 
as previously described (Kaprielian and Patterson, 1993). 
Molecular cloning of rat CD9 
Single strand cDNA was prepared from adult rat SCG and ScN RNA 
using Maloney murine leukemia virus reverse transcriptase (Promega) 
and oligo-dT primers. Two primers, NT! 7 and CTI 9, representing 
portions of the N- and C-terminus of human/bovine CD9, respectively, 
were synthesized as follows: NT17, 5'-ATGCCGGTCAAAGGAGG-
3'; CT19, 5'-AAGCTTGACTCTAGACCAT-3'. Rat CD9 DNA was 
amplified by adding these two primers and Taq DNA polymerase (Pro-
mega) to SCG or ScN cDNA, and carrying out the following polymerase 
chain reaction (PCR): 40 cycles of 95°C for 1 min, 52°C for 1.5 min, 
72°C for 1.5 min, and a final incubation at 72°C for 10 min. The PCR 
products amplified from both the SCG and ScN templates each con-
tained a major band of the expected size (678 bp) on 2% agarose gels. 
These products were isolated and inserted into the Smal site of the 
pBluescript II SK+ (Stratagene) vector. 
DNA sequence analysis 
Two, independent subclones derived from each of the original PCR 
products named [Full ScN #13 and Full ScN #42 (from ScN cDNA), 
and Full SCG #3 and Full SCG #8 (from SCG cDNA)] were sequenced 
by the dideoxy chain termination method (Sanger et al., 1977) using 
double-stranded DNA as template and T7 DNA polymerase (Sequen-
ase, U.S. Biochemicals). Both strands of each subclone were sequenced 
not only with the T3, SK, KS, and T7 primers (Stratagene), but also 
with the four internal primers: RCD9 189, 5'-GCTGGGGCCCTCAT-
GATG-3'; RCD9 255, 5'-CTGGGATTGTTCTTCGGA-3'; RCD9 490, 
5'-GAACAAGGATGAGCCCAG-3'; RCD9 550, 5'-GACATCTG-
CCCCAAAAAG-3'. The sequences of these subclones proved to be 
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identical except that at each of four positions one of the clones contained 
a nucleotide that was different from the one present in the other three. 
This analysis yielded a consensus nucleotide sequence for rat CD9 (see 
Fig. 2). Eight additional PCR-isolated cDNAs (four each from ScN and 
SCG RNA) were sequenced in one direction using the primers listed 
above. Six of these proved to be identical to the consensus rat CD9 
sequence, while two contained single nucleotide differences. We attrib-
ute all of the single nucleotide changes to PCR errors. Searches for related 
sequences were performed using the BLAST program. 
Expression of rat CD9 in CHO cells 
Subcloning of CD9 cDNA. The Full ScN #13 cDNA was inserted into 
the pBluescript II SK+ vector (described above). Digestion with BamHI 
and Xhol yielded a fragment containing all of the CD9 cDNA and 
approximately 50 bp of vector. This fragment was then subcloned into 
the BamHl/XhoI linearized eukaryotic expression vector, pcDNAI/neo 
(Invitrogen). After transformation of bacteria, a plasmid with the intact 
5' -3' CD9-cDNA insert was selected. Large amounts of this DNA were 
purified (Qiagen plasmid kit) and subsequently used for transfection. 
Transfection. CHO cells were transfected by lipofectin (BRL) (Feigner 
et al., 1987). Briefly, cells were plated at 2.5 x 10'/100 mm dish and 
grown overnight at 37°C in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS, Hyclone) 
and penicillin-streptomycin (50 U/ml and 50 µglml, respectively). Li-
pofectin (25 µg) was mixed with 5 µg rat CD9 cDNA (construct) in 200 
µl of serum-free DMEM and added to the cells in 5 ml of serum-free 
medium. The cells were then incubated for 5 hr after which the lipo-
fectin-DNA medium was replaced by 10 ml of serum-containing DMEM. 
Cells were finally incubated at 37°C for 48 hr prior to the addition of 
400 µg!ml G4 l 8. Twelve days later colonies were isolated using cloning 
cylinders. 
Fusion protein analysis. The MBP-CD9 fusion protein was generated 
by in-frame fusion to a maltose binding protein (New England Biolabs). 
Briefly, to obtain a cDNA encoding the large, putative extracellular 
domain of rat CD9, a PCR was carried out using a primer corresponding 
to amino acids 111 to 116 (ATGGATCCCACAAGGACGAGGTGAT-
T AA), and another corresponding to amino acids 184-190 
(ATAAGCTTCACTTGCTGTGGAAGACCTC), along with Full ScN 
#13 as a template. To facilitate the cloning, a BamHI site was incor-
porated into the 5' end of the forward primer(underlined), and a HindIII 
site was incorporated into the 5' end of the backward primer (under-
lined). The PCR product was extracted with phenol and chloroform, 
digested with BamHI and HindIII, and ligated with pMal-c2 vector that 
had been digested with BamHI and HindIII. The expression of this 
fusion protein was induced by IPTG (isopropyl-~-o-thiogalactopyran­
oside), and sonicated E. coli extracts were subjected to SOS-PAGE 
(Smith and Johnson, 1988). 
lmmunoprecipitation. Stably transfected CHO cell lines were grown 
to confluency in 100 mm tissue culture dishes containing DME-10% 
FBS. For metabolic labeling, the medium was replaced with 5 ml of 
DME (without cysteine or methionine or serum) to which 500 µCi (final 
concentration= I 00 µCi/ml) 35S-methionine-translabel (ICN) had been 
added, and the cells were then incubated for 3 hr at 3 7°C. Following 
the labeling period, cells were washed 3 x with 5 ml of phosphate-
buffered saline (PBS; 0.9% NaCl, 100 mM NaP04 ) and lysed with 2 ml 
of protease-inhibitor containing low salt homogenization buffer (see 
above) containing I% CHAPS (Boehringer Mannheim). After multiple 
rounds of trituration and vortexing, the cell extract was centrifuged at 
I 00,000 x g for I hr in a Beckman Type 50 rotor. The resulting su-
pernatant (2 ml) was mixed with 150 µI of Protein G-conjugated se-
pharose beads (Pharmacia) and rotated end-over-end for 3 hr at room 
temperature. Then, 500 µI of the preabsorbed extract was mixed with 
500 µl of ROCA!, ROCA2, or B2Cl I hybridoma supernatant and 
rotated end-over-end for 12-16 hr at 4°C. After this incubation, 30 µI 
of Protein G-conjugated sepharose beads were added to the mixture 
and the incubation was continued for another 3 hr at room temperature. 
The beads were then centrifuged in a microfuge, the supernatant re-
moved, and the beads washed three times with PBS containing 0.05% 
Tween-20 by a series ofresuspensions and centrifugations. After a final 
wash in PBS without detergent, the beads were placed in l x nonreducing 
sample buffer for 5 min to elute bound antigens (Kaprielian and Pat-
terson, 1993). Proteins were subjected to one-dimensional SOS-PAGE, 
and stained and destained as previously described (Kaprielian and Pat-
terson, 1993). Immediately prior to drying, the gels were incubated in 
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Figure J. ROCA 1, ROCA2, and B2CI 1 each bind a 26 kDa protein in extracts of adult rat sciatic nerves and platelets. One percent NP-40 extracts 
of adult rat sciatic nerve and platelet membrane/cytoskeletal fractions were subjected to SOS-PAGE and immunoblot analysis as described in 
Materials and Methods. Each mAb binds a 26 kDa protein in both sciatic nerve (Sc.N.) and platelet (PLAT.) extracts. Primary antibody binding 
was visualized with a peroxidase-conjugated goat anti-mouse IgG secondary antibody. Approximately 40 µg of protein was loaded in each lane. 
Amplify (Amersham) for 30 min at room temperature. For autora-
diography, dried gels were exposed to Kodak X-OMAT AR film for 
12-24 hr at - 80"C. 
Immunocytochemistry. Transfected CHO cells were harvested, re-
plated on sterile glass coverslips in serum-containing DMEM and grown 
for another 48 hr. Surface labeling of the cells with ROCA2 and B2Cl 1 
hybridoma supematants was carried out as described in Hadjiargyrou 
and Patterson, 1994. Cells were photographed using a Nikon fluores-
cence microscope (Diaphot 300). 
RNA Jsolaiion and Northern analysis. Total RNA was prepared from 
various tissues as described by (Chomczynski and Sacchi 1987. RNA 
was separated on 1.5% agarose-formaldehyde gels, transferred to Hy-
bond nylon membrane (Amersham), and UV cross-linked (Stratagene). 
The PCR was used to generate CD9, MBP and P0 DNA by using the 
cloned cDNAs as templates, along with universal and reverse PCR 
primers. DNA for the 3' end of 28S rRNA was amplified using rat 
genomic DNA as the template and the following two PCR primers: 
forward, TGAAGCAGAA TTCACCAAGC; backward, GTCGAGGG-
CTGACTTTCAA T (Choi, 1985). Each of the DNA probes were labeled 
with 32P by the random priming method (Feinberg and Vogelstein, 
1983). Blots were hybridized and washed according to Cho et al., 1991 . 
The same blot was reused multiple times by placing the filter in boiling 
water for 1 min to strip previously bound radioactivity. Blots were 
exposed to either Kodak X-OMAT AR film or Molecular Dynamics 
Phosphor screens. Radioactivity was quantitated by scanning the Phos-
phor screens with a Phosphorimager 400S (Molecular Dynamics) and 
computations performed with lMAOEQUANT software. 
In situ hybridization. The Full ScN # 13 cDNA was linearized with 
BamHI or EcoRI and transcribed with T7 or T3 RNA polymerase 
(MEGAscript Transcription Kit, Ambion) to generate antisense and 
sense rat CD9 RNA probes, respectively. Nonradioactive labeling was 
achieved by incorporating digoxygenin-11-UTP (Boehringer Mann-
heim) into the RNA probes during the transcription reaction. Tissue 
sections (15 µm thick) on glass slides were hybridized in plastic slide 
mailers with digoxygenin-labeled probes by a modification (Birren et 
al., 1993) of the procedure of Harland (1991) with the following excep-
tions. All tissue sections were placed on untreated Super frost/Plus 
microscope slides (Fisher Scientific). Prehybridization and hybridiza-
tion steps were carried out at 50°C (instead of 60"C) for those sections 
containing sciatic or intercostal nerves. The alkaline phosphatase-«>n-
jugated anti-digoxygenin Fab fragments were preabsorbed with extracts 
of tissue parts dissected from developing or adult rats, depending on 
the age of the tissue to be examined. 
Results 
Expression of the ROCA surface antigen in platelets 
To determine whether the ROCA mAbs recognize a 26 kDa 
protein in hematopoietic cells we performed immunoblots on 
Figure 2. Top, Amino acid sequence alignment of RAT, MOUSE, HUMAN, MONKEY, and BOVINE CD9. The putative transmembrane 
domains (TMJ- IV) are shaded. Identical residues between sequences are indicated by dashes. Bottom, Proposed topological model ofCD9. Open 
circles represent residues that are identical across species. Solid circles identify interspecies amino acid differences. The two lightly shaded circles 
identify the positions of the two amino acids that are missing in rat CD9 (see top). The asterisk denotes the asparagine residue that is a possible 
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Figure 3. The 26 kDa ROCA cell surface antigen is rat CD9. A, ROCAI (lane I), ROCA2 (lane 2), and B2Cl l (lane J)each immunoprecipitate 
a 26 kDa protein from a 1% CHAPS extract of " S-Met labeled CHO cells that had been stably transfected with the Full ScN. #13 cDNA, encoding 
rat CD9. The stably transfected CHO cell clone used in this particular experiment was CD9-y. The arrow indicates the position ofCD9 (26 kDa). 
B, ROCA2 and B2Cl I, but not ROCAI label the surfaces ofCD9'Y cells. Live CD9'Y cells were sequentially incubated with the various mAbs and 
a goat anti-mouse lgG ftuorescein-conjugated secondary antibody. The top portion of each panel is a phase micrograph, while the bottom portion 
is a fluorescence micrograph of the same field. C, ROCAI, ROCA2, and B2Cl 1 do not label the surfaces ofnontransfectcd CHO cells. Live CHO 
cells were sequentially incubated with the various mAbs and a goat anti-mouse lgG ftuorescein-conjugated secondary antibody. The top portion 
of each panel is a phase micrograph, while the bottom portion is a fluorescence micrograph of the same field. 
+ + + 
-
ROCA1 ROCA2 B2C11 
detergent-solubilized membrane/cytoskeletal fractions of adult 
rat platelets using ROCA! and ROCA2. We also used mAb 
B2C l I (Akeson and Warren, 1984) after finding that this mAb 
binds strongly to the affinity-purified 26 kDa ROCAl/2 antigen 
from adult rat peripheral nerves (data not shown; mAb B2Cl I 
is further characterized in the accompanying article; Hadjiar-
gyrou and Patterson, 1994). Each mAb recognizes a 26 kDa 
protein in the platelet extract that co migrates with the previously 
described peripheral nerve protein (Fig. I). In addition, ROCA2 
and B2C 11 each bind larger, glycosylated forms of the 26 kDa 
protein (Kaprielian and Patterson, 1993) in both platelet and 
nerve extracts. These results are consistent with the possibility 
that the 26 kDa ROCA antigen may be rat CD9. 
Isolation of rat CD9 cDNA clones 
To clone the cDNA encoding rat CD9, we used the PCR with 
nondegenerate oligonucleotide primers corresponding to the 
NH2-terminal and COOH-terminal sequences ofhuman/bovine 
CD9. Amplifications were performed using cDNA templates 
derived from adult rat sciatic nerve or superior cervical sym-
pathetic ganglia mRNA. In both cases, 690 bp products were 
obtained (data not shown). This corresponds to the expected 
size for a cDNA clone encoding the entire rat CD9 protein based 
upon the nucleotide sequences of human and bovine CD9. Two 
cDNAs obtained using the sciatic nerve (ScN) template, full 
ScN# 13 and #42, as well as two cDNAs obtained using the 
superior cervical sympathetic ganglia (SCG) template, full SCG#3 
and #8, were sequenced in both directions (see Materials and 
Methods), and found to be nearly identical (see Materials and 
Methods). In addition, we have isolated and characterized three 
full length cDNAs encoding rat CD9 from a postnatal day 9 rat 
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Figure 4. R OCA2 and B2C 11 bind the 
large, putative extracellular domain of 
rat CD9. Proteins within extracts gen-
erated from E. coli expressing the MBP-
CD9 fusion protein ( +) or MBP (-) 
were subjected to SDS-PAGE and im-
munoblot analysis. ROCA2 and B2Cl 1, 
but not ROCA I, bind a 49 kDa protein 
present only in extracts containing the 
MBP-CD9 fusion protein. Primary an-
tibody binding was visualized with a 
peroxidase-conjugated goat anti-mouse 
lgG secondary antibody. The control 
reflects the binding of the secondary an-
tibody alone. 
sciatic nerve cDNA library. The sequences of these clones pre-
cisely match those of the PCR products (data not shown). 
The rat protein is 95% identical to mouse CD9, and 93%, 
92%, and 83% identical to the human, monkey, and bovine 
proteins, respectively (Fig. 2). Rat, mouse, and bovine CD9 each 
consist of 226 amino acid residues, while human and monkey 
CD9 are comprised of 228 amino acids. Only rat and mouse 
CD9 contain a string of seven amino acids between positions 
120 and 126, ELQEFYK, which is identical to the sequence of 
a tryptic peptide generated from the affinity-purified 26 kDa 
protein (Fig. 2 and Kaprielian and Patterson, 1993). At position 
50 in the rat sequence there exists one putative, N-linked gly-
cosylation site (NHS). A similar site is present in the mouse, 
human, monkey and bovine sequences; each of these sequences, 
however, possesses additional asparagine residues immediately 
before the consensus asparagine. Mouse and bovine CD9 con-
tain one, while human and monkey CD9 contain two additional 
asparagines (Fig. 2). Consistent with previous observations (Ru-
binstein et al., I 993b), the majority of interspecies amino acid 
differences in the CD9 protein are present in the large extra-
cellular domain (Fig. 2). 
The 26 kDa ROCA antigen is rat CD9 
To confirm the identity of the 26 kDa ROCA antigen, the rat 
CD9 cDNA clone, full ScN # 13, was subcloned into the pc-
DNAI/neo expression vector (InVitrogen) and introduced into 
CHO cells. Multiple, stably transfected, clonal CHO cell lines 
were isolated through 0418 selection. ROCAl , ROCA2, and 
B2CI I each immunoprecipitate a 26 kDa protein from deter-
gent extracts of such cell lines (Fig. 3A). Isotype-matched mAbs 
do not immunoprecipitate CD9 (data not shown). In addition, 
ROCA2 and B2C I I, but not ROCA! , strongly and uniformly 



























Figure 5. Rat CD9 mRNA is expressed by a wide range ofneural and 
non-neural tissues. A, Northern blot analysis was performed using 2 µg 
of total RNA derived from various adult rat tissues and 32P-labeled Full 
ScN #13 (rat CD9) and 28S cDNA probes. The top panel shows the 
hybridization of the rat CD9 probe to a 1.3 kb species present in many 
tissues, and the bottom panel shows the hybridization of the 28S probe 
to all tissues. The apparent size difference between platelet CD9 mRNA 
and CD9 mRNAs in other tissues is due to frowning of this particular 
gel and the placement of the platelet lane at the extreme edge of the gel. 
B, The radioactivity in all lanes was quantified using a Phosphorimager, 
and plotted as the ratio ofCD9 mRNA to 28S rRNA versus tissue type. 
label the surfaces of these same cells (Fig. 38). None of our anti-
rat CD9 mAbs bind the surfaces of (Fig. 3C), or immunopre-
cipitate any protein from (data not shown), the mock-transfected 
CHO cells (Fig. 3C). 
To prove that ROCA2 and B2Cl I recognize the large, pu-
tative extracellular domain ofCD9, we generated a fusion pro-
tein (see Materials and Methods) containing residues 111-190 
of rat CD9. Consistent with the fact that ROCA2 and B2CJ 1 
bind living cells expressing the entire rat CD9 protein, ROCA2 
and B2CI I, but not ROCA I, bind this fusion protein (Fig. 4). 
Expression of rat CD9 mRNA 
Tissue distribution. Northern blot analysis was performed using 
total RNA from various adult rat tissues and the full ScN #13 
rat CD9 cDNA probe. This probe identifies a 1.3 kb RNA band 
in a wide range of tissues (Fig. 5A). For each tissue, the ratio of 
CD9 mRNA to 28S rRNA was calculated (Fig. 5B). Based upon 
this analysis, adult rat platelets are the most abundant source 
of CD9 mRNA. This is consistent with the known distribution 
ofCD9 in other species. Superior cervical ganglia (SCG), sciatic 
nerve (ScN) and spinal cord all express high levels of CD9 
mRNA. Low, but clearly detectable levels are present in dorsal 
root ganglia (DRG) and cerebellum, but very little signal is 
detected in the cerebrum. While significant levels ofCD9 mRNA 
are present in a number of non-neural tissues such as esophagus, 
heart, lung, adrenal, spleen, and kidney, no hybridization was 
observed to liver or skeletal muscle RNA. The rat CD9 probe 
also hybridizes to a minor, 3.2 kb species in superior cervical 
ganglia and sciatic nerve RNA (Fig. 5A; see Discussion). 
Cell type specific expression. In situ hybridization studies were 
performed to unambiguously determine whether neurons as well 
as glia express CD9 mRNA. Digoxygenin-labeled antisense and 
sense RNA probes derived from the full ScN #13 cDNA were 
hybridized to sections of selected neural and non-neural tissues. 
The cytoplasm of adult rat SCG and DRG neurons is clearly 
labeled by the antisense probe (Fig. 6a,c). While most of the 
neurons present within SCG sections are labeled by the rat CD9 
probe, only a small subset of DRG neurons detectably express 
CD9 mRNA. This finding is consistent with a significantly lower 
level of CD9 mRNA in the DRG as compared to the SCG, as 
determined by Northern analysis. Schwann cells present within 
sections of adult rat peripheral nerve also clearly express CD9 
mRNA (Fig. 6b). The identification of these cells as Schwann 
cells is based upon (1) labeling of very similar appearing cells 
using Po and MBP RNA probes (data not shown), (2) the bi-
polar, longitudinam morphology of the labelled cells, and (3) the 
large number ofCD9+ cells. In addition, the cytoplasm of chro-
maffin cells in the adrenal medulla (Fig. 6d) and epithelial cells 
in the esophagus (data not shown) strongly label with the an-
tisense CD9 probe. In all cases, no hybridization was detected 
with the sense probe (data not shown). 
Positional and developmental expression. We also examined 
the rostrocaudal distribution ofCD9 mRNA. Northern analysis 
detects essentially equivalent levels of the 1.3 kb CD9 mRNA 
(normalized to the amount of myelin basic protein (MBP) 
mRNA) in adult rat intercostal nerves taken from various ros-
trocaudal levels (Fig. 7). Similarly, the number ofSchwann cells 
expressing rat CD9 mRNA does not appear to vary significantly 
between rostral and caudal nerves (data not shown). 
Northern and in situ analyses were also used to determine if 
CD9 mRNA expression is developmentally regulated in post-
natal rat ScNs. We performed similar analyses with probes spe-








Figure 6. Rat CD9 mRNA is expressed by peripheral neurons, Schwann cells and chromaffin cells. Digoxygenin-labeled antisense RNA probes 
derived from the Full ScN # 13 cDNA were hybridized to cryosections of adult rat SCG (a), sciatic nerve (b), DRG (c), and adrenal gland (d). The 
cytoplasm of neurons present within the SCG and DRG sections (a, c) and bipolar Schwann cells in the sciatic nerve section (b) are all brightly 
labeled. The left portion of the adrenal gland section (d) contains strongly labeled chromaffin cells of the adrenal medulla, while the right portion 
shows the unlabeled cortex. 
cific for Po and MBP, two myelin genes whose expression is 
known to be developmentally regulated in these nerves (Wiggins 
et al., 1975; Lees and Brostoff, 1984; Lemke and Axel, 1985; 
Stahl et al., 1990). Northern analysis shows that the mRNA 
expression of all three genes dramatically rises from a low, but 
clearly detectable level in newborn sciatic nerves, to maximum 
levels by postnatal day 14 (Fig. 8A). By day 60, CD9, MBP, and 
Po mRNA expression is downregulated to adult levels. Jn situ 
hybridization performed with the full ScN #13 CD9 antisense 
probe confirms these results. While only a small number of 
scattered Schwann cells express CD9 mRNA in the newborn 
ScN, large numbers are strongly labeled by postnatal days 7 and 
14 (Fig. 8B). By day 60, the number oflabeled Schwann cells is 
reduced to adult levels. Similar results were obtained with a 
MBP antisense probe (data not shown). 
Discussion 
We previously generated the mAb, ROCAl , which recognizes 
an epitope on a 26 kDa cell surface protein that is preferentially 
accessible in rostral intercostal nerves and rostral sympathetic 
ganglia (Suzue et al., 1990; Kaprielian and Patterson, 1993). 
Two other mAbs, ROCA2 and B2Cl l, also recognize the 26 
kDa protein, but do not detect a rostrocaudal, immunohisto-
chemical gradient. Amino acid sequences obtained from the 
affinity-purified protein suggested that it could be the rat ho-
molog of CD9 (Kaprielian and Patterson, 1993). We present 
here the isolation of cDNA clones encoding rat CD9 from pe-
ripheral nerves and ganglia, and demonstrate that the ROCA 
cell surface protein is, in fact, rat CD9. We also show that rat 
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Figure 7. The expression of rat CD9 mRNA is not graded along the 
rostrocaudal axis. Northern blot analysis was performed using 2 µ.g of 
total RNA derived from adult rat intercostal nerves taken from various 
rostrocaudal levels, and 32P-labeled Full ScN # 13 (rat CD9) and MBP 
cDNA probes. The identical transfer was probed with each cDNA in 
succession after removal of previously bound radioactivity. The radio-
activity representing the hybridization of each probe was quantified 
using a Phosphorimager and the ratio of CD9 mRNA to MBP mRNA 
plotted versus rostrocaudal position. 
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and Schwann cells, as well as in certain parts of the central 
nervous system. In addition, we demonstrate that while CD9 
mRNA is not positionally regulated in intercostal nerves, it is 
coordinately regulated with myelin genes during postnatal ScN 
development. 
The ROCA cell surface 26 kDa protein is rat CD9 
Using the PCR, as well as direct cDNA library screening, we 
obtained cDNA clones representing the probable entire coding 
region of rat CD9 from SCG and ScN. The high degree ofamino 
acid identity between the deduced protein sequence of the rat 
form and the mouse (95%), human (93%), monkey (92%), and 
bovine (83%) forms strongly supports the identification of these 
cDNAs as rat CD9. Our CD9 mAbs bind the cell surface and 
fail to cross-react across species. The larger, putative extracel-
lular loop that contains the majority of interspecies amino acid 
differences (Martin-Alonso et al., 1992; Reynolds et al., 1992; 
Wright et al., 1993), also contains the epitopes recognized by 
ROCA2 and B2Cl 1, as shown by positive binding to immu-
noblots of a fusion protein containing residues 111-190 of the 
rat protein. Interestingly, ROCAl does not bind this fusion 
protein, even though it binds the full-length protein very well 
(Fig. 3A). This result, coupled with the finding that ROCAl can 
bind to the complete fusion protein on immunoblots and to 
intact primary cells, suggests that the position-dependent ROCA 1 
epitope resides on the smaller extracellular loop (residues 36-
55) ofCD9. 
The deduced rat CD9 protein sequence contains the same 
string of seven amino acids, ELQEFYK, as one of the tryptic 
peptides generated from the affinity purified 26 kDa protein 
(Kaprielian and Patterson, 1993). The N-terminal 14 amino 
acids (deduced from the cDNA) of the rat protein, 
PVKGGSKC/KYLLF, are similar to those obtained by se-
quencing the N-terminus of the affinity-purified ScN protein, 
XVKGGIDEVFYLLF (Kaprielian and Patterson, 1993). All 12 
of the rat CD9 cDNAs, contain the amino acid string, SKCIK, 
not IDEVF, between positions 6 and 10 within this string. This 
discrepancy may be due to protein sequencing errors or to the 
existence of two forms of rat CD9 with different N-terminal 
sequences. Support for the protein sequencing error explanation 
comes from previous attempts to sequence the N-terminus of 
human CD9; three different groups failed to unambiguously 
determine the identity of all five residues (Higashara et al., 1990; 
Boucheix et al., 1991; Lanza et al., 1991). 
We performed additional PCR reactions to search for a form 
of CD9 containing the amino acid string IDEVF from amino 
acid position 7 to 11. Sequence analysis of 23 distinct clones 
identified either the same form of rat CD9 that we report here 
(N-terminus: MPVKGGSKCIK) or nonsense sequences (data 
not shown). Despite these results, however, we cannot rule out 
the existence of another, perhaps alternatively spliced, form of 
rat CD9. 
Immunoprecipitation ofa 26 kDa protein by ROCA I, ROCA2, 
and B2Cl I from detergent extracts of CHO cells stably trans-
fected with a rat CD9 cDNA confirms the identity of the ROCA 
cell surface antigen as CD9. Interestingly, ROCA!, unfike 
ROCA2 and B2C 11, does not label the surfaces of the trans-
fected cells. ROCA! does not bind the surface of a variety of 
other cell types that are strongly labeled with ROCA2 and B2Cl 1 
(Hadjiargyrou and Patterson, 1994, and unpublished observa-
tions), but does bind to the surfaces of primary Schwann cells 
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Figure 8. The expression of rat CD9 mRNA is developmentally reg-
ulated in postnatal sciatic nerves. A, Northern blot analysis was per-
formed using 2 µg of total RNA derived from sciatic nerves taken from 
postnatal rats of various ages, and 32P-labeled Full ScN #13 (rat CD9), 
MBP, Po, and 28S cDNA probes. The identical transfer was probed 
with each cDNA in succession after removal of previously-bound ra-
dioactivity. The radioactivity representing the hybridization of each 
probe was quantified using a Phosphorimager and the ratio of the various 
mRNAs to 28S rRNA plotted versus developmental age. B, Digoxy-
genin-labeled antisense RNA probes derived from the Full ScN #13 
cDNA were hybridized to cryosections of developing postnatal rat sci-
atic nerves. The number of Schwann cells expressing rat CD9 signifi-
cantly increases by postnatal day 7, and then decreases to adult levels 
by postnatal day 60. 
in vivo observations (Kaprielian and Patterson, 1993), these 
results suggest that the ROCA! epitope may not always exist 
in an accessible state on the cell surface. In this regard, the 
transfected CHO cells may represent a model system for further 
study of epitope masking on CD9. 
Expression of rat CD9 mRNA 
Tissue and cell type specific expression. We detect a major 1.3 
kb band of rat CD9 mRNA in many, but not all adult tissues. 
Of the tissues examined, only liver and skeletal muscle contain 
no detectable rat CD9 mRNA. The significant levels of CD9 
mRNA present in certain neural tissues, including adult rat 
peripheral nerves and ganglia, spinal cord, and cerebellum, are 
consistent with the isolation ofrat CD9 cDNAs from adult SCG 
and ScN DNA templates. Other studies have identified a similar 
size mRNA band in Northern blots using CD9 cDNA probes 
(Boucheix et al., 1991; Martin-Alonso et al., 1992). However, 
an extensive analysis ofCD9 mRNA tissue distribution has not 
previously been described. The rat CD9 probe also hybridized 
weakly to a 3.2 kb mRNA band. While the nature of this species 
is not known, this band is present in a wide variety of tissues 
and cell lines (data not shown). 
In situ hybridization shows that peripheral neurons, glia and 
chromaffin cells express rat CD9 mRNA. In particular, neurons 
in SCG and DRG, Schwann cells in ScNs, and chromaffin cells 
in the adrenal medulla are all strongly labeled by the CD9 an-
tisense probe. Neuronal labeling is clearly detectable in early 
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Figure 8. continued. 
is maintained into adulthood. We have previously shown that 
satellite cells in sections of adult SCG are DRG are labeled by 
ROCAl and 2 (Suzue et al., 1990; Kaprielian and Patterson, 
1993; Tole and Patterson, 1993), as well as B2Cl l (unpublished 
observations). We cannot, however, unambiguously detect label 
in the cytoplasm of ganglionic satellite cells in our in situ anal-
ysis. This may reflect the presence oflower levels ofCD9 mRNA 
in satellite cells than in neurons. Taken together, the northern 
blot and in situ hybridization results confirm and extend pre-
vious immunoblot and immunohistochemical analyses dem-
onstrating that rat peripheral neurons, Schwann cells, and chro-
maffin cells all express CD9 (Kaprielian and Patterson, 1993; 
Tole and Patterson, 1993). To our knowledge, this is the first 




















study utilizing in situ hybridization to localize CD9 mRNA in 
any tissue. 
Positional and developmenta:l expression. Northern blot anal-
ysis shows that equivalent levels ofCD9 mRNA are present in 
rostral and caudal intercostal nerves. This result is consistent 
with previous immunoblot analyses demonstrating that both 
ROCAI and ROCA2, as well as B2Cl I (Z. Kaprielian, unpub-
lished observations), detect uniform levels of the 26 kDa, rat 
CD9 protein in rostral and caudal intercostal nerves (Kaprielian 
and Patterson, 1993). These findings all support the notion that 
ROCA I binding reflects the presence of a positionally graded 
epitope, rather than a rostrocaudal gradient ofCD9 protein. Of 
course, the formal possibility remains, that ROCAI recognizes 
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an as yet unidentified third antigen (in addition to CD9 and 
peripherin) whose distribution may directly account for the im-
munohistochemical gradient. 
Northern blot and in situ hybridization analyses shows that 
the expression ofCD9 mRNA is significantly upregulated during 
early postnatal SCN development, and downregulated in the 
adult. This time course suggests that CD9 and peripheral myelin 
gene expression (Wiggins et al., 197 5; Lees and Brostoff, 1984; 
Lemke and Axel, 1985; Stahl et al., 1990) are coordinately reg-
ulated during postnatal development. Together with the ex-
pression of the CD9 protein on neuronal as well as Schwann 
cell surfaces, these developmental data further suggest a role for 
CD9 in mediating Schwann cell-axon interactions during my-
elination. Moreover, the results of antibody perturbation ex-
periments strongly suggest a role for CD9 in neural cell adhesion 
(Hadjiargyrou and Patterson, 1994). 
Interestingly, the developmental expression ofCD9 also par-
allels that of another peripheral myelin gene PMP-22 (Welcher 
et al., 1991; Snipes et al., 1992). PMP-22 is the target of mu-
tations that result in the trembler phenotype in mice and in 
Charcot-Marie-Tooth disease ( CMT) Type 1 a in humans (Snipes 
et al., 1993). Although PMP-22 bears no sequence homology 
with members of the CD9 tetraspan family, this protein has 
also been implicated in growth regulation and possesses four 
putative membrane-spanning domains (Lemke, 1993; Snipes et 
al., 1993; Suter et al., 1993). In this regard, it is interesting to 
note that another four transmembrane spanning domain mol-
ecule, connexin 32 (Cx32), has recently been shown, like MBP, 
PO, and PMP-22, to be downregulated in transected sciatic nerves 
(S. Scherer, personal communication). Moreover, patients with 
X-linked CMT possess mutations in the gene encoding Cx32 
(Bergoffen et al., 1993). Thus, it seems possible that proteins 
containing the four transmembrane domain structural motif 
may play important roles in peripheral nerve myelination. 
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